Clinical Trials Browser

Interventional × SCLC × Platinum × Clear all

NCT05844150 2025-03-12

A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC

Phase 2 Active not recruiting

SCLC